Labshake search
Citations for Tocris :
4351 - 4400 of 7257 citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... D-AP5 (Tocris Bioscience, 0106, 30 mM), an N-methyl-D-aspartate receptor blocker ...
-
bioRxiv - Neuroscience 2021Quote: ... We injected 200 nl of 5 mM -(−) bicuculline methiodide (Tocris Bioscience, Bristol, UK) with the syringe pump at 100 nl/min ...
-
bioRxiv - Neuroscience 2021Quote: ... 4- aminopyridine (Tocris Bioscience, 50 µM, 5 min-2hrs or 20hrs), AP5 (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... 40 µM bicuculine (Bic, Tocris #0130/50) and 50 µM 4-aminopyridine (4AP ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 µM 4-aminopyridine (4AP, Tocris #940) were added to the culture media at 37° ...
-
bioRxiv - Neuroscience 2021Quote: ... (2R)-amino-5-phosphonopentanoate (APV) was purchased from Tocris Bioscience (Bio-Techne Ltd ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Neuroscience 2021Quote: Picrotoxin (1128, Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... NMDA receptor (R) dependency was tested by application of an NMDAR antagonist (APV 50 µM, DL-2-Amino-5-phosphonopentanoic acid, Tocris, Germany) in the bath solution ...
-
bioRxiv - Neuroscience 2021Quote: ... Intracellular infusion of ryanodine (100 µM, Tocris, Germany, infusion for 15 min) was used to block ryanodine receptors of internal calcium stores ...
-
bioRxiv - Neuroscience 2021Quote: The contribution of activity-dependent incorporation of GluA1 subunit containing AMPA receptors to expression of low repeat t-LTP was verified by postsynaptic application of Pep1-TGL (100 µM, Tocris, Germany) via the patch pipette solution ...
-
bioRxiv - Neuroscience 2021Quote: ... IP3 receptors were blocked by bath application of 2-APB (100 µM, Tocris, Germany, micro-perfusion pump), 2-APB was applied at least 15 min prior t-LTP induction and was present throughout the recordings ...
-
bioRxiv - Neuroscience 2021Quote: ... or the mGluR5 receptor antagonist MPEP (10 μM, Tocris, Germany) alone ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2021Quote: Heparin sodium salt solution (Tocris) at 20 mg/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... TTX (1 μM, Tocris Bioscience), 4-AP (100 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... 4-AP (100 μM, Tocris Bioscience), and GBZ (10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and GBZ (10 μM, Tocris Bioscience). For whole-cell recordings ...
-
bioRxiv - Neuroscience 2021Quote: For imaging experiments with reserpine (Tocris Bioscience), reserpine was added to the medium (1 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... For L-3,4-Dihydroxyphenylalanine (L-DOPA, Tocris Bioscience) treatment ...
-
bioRxiv - Neuroscience 2021Quote: The TRPA1-specific inhibitor HC03003118 (Tocris Bioscience) was solubilized in 16% DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... we used bath applied NASPM (1-Naphtyl acetyl spermine trihydrochloride, 100 µM, Tocris, Germany) or IEM-1460 (N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... or the NO synthase inhibitor L-NAME (200 µM; Tocris, UK) to our recording ACSF.
-
bioRxiv - Neuroscience 2021Quote: The Cck1 receptor (Cck1R) agonist A71623 (Tocris Biosciences) was suspended in 20mM PBS according to the manufacturer’s directions ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2021Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Neuroscience 2021Quote: ... and Picrotoxin (Tocris, 1128, 50 μM) dissolved in HEPES-aCSF or control HEPES-aCSF for 30 minutes ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600, 1 μM; D(-)-2-Amino-5 phosphonopentanoic acid (APV) ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2021Quote: ... Rolipram (Tocris, 0905, 0.1 μM), and Picrotoxin (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... neurons were treated with cLTP solution containing Forskolin (Tocris, 1099, 50 μM), Rolipram (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600, 1 μM; LY-367385, Sigma, L4420, 100 μM; MPEP, Tocris, 1212, 10 μM). Type I mGluR agonist DHPG (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 µM AM251 (Tocris Bioscience). For acute treatments ...
-
bioRxiv - Neuroscience 2021Quote: ... NBQX (10 μM, Tocris bioscience; 1044), picrotoxin (100 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... Whole cell currents were recorded (see electrophysiology below) with synaptic transmission and action potentials blocked by CPPene (10 µM, Tocris bioscience; 1265), NBQX (10 μM ...
-
bioRxiv - Neuroscience 2021Quote: Tetrodotoxin (TTX, Tocris), a blocker of sodium channels in plasma membranes ...
-
bioRxiv - Neuroscience 2021Quote: ... and Picropodophyllin (PPP) were from Tocris.
-
bioRxiv - Neuroscience 2021Quote: ... Other drugs were from Tocris Bio-Techne (Lille ...
-
bioRxiv - Neuroscience 2021Quote: ... n=20) group were randomized to receive either saline or GLP-1R antagonist Exendin-3(9-39)amide (Ex-9) (Tocris Bioscience, UK) (85 μg/kg dissolved in saline ...
-
bioRxiv - Neuroscience 2021Quote: Bilateral mosaic tadpoles expressing GCaMP6s at stage 48 were immobilized in 2 mM pancuronium dibromide (Cedarlane/Tocris 0693) and embedded in 1% low melting point agarose in a petri dish filled with 0.1X MBSH ...
-
bioRxiv - Neuroscience 2021Quote: ... or kainic acid (Tocris, 1 μM; Tocris 0222) were bath-applied sequentially (ensuring that holding current returned to the original control level before subsequent drug application ...
-
bioRxiv - Neuroscience 2021Quote: ... N-methyl-D-aspartic acid (NMDA, 10 μM; Tocris 0114) or kainic acid (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... cells were whole-cell voltage-clamped at −40mV and recorded in the presence of the GABAAR antagonist Gabazine (10 μM, Tocris 1262). N-methyl-D-aspartic acid (NMDA ...
-
bioRxiv - Neuroscience 2021Quote: ... or kainic acid (Tocris, 1 μM; Tocris 0222) were bath-applied sequentially (ensuring that holding current returned to the original control level before subsequent drug application ...
-
bioRxiv - Neuroscience 2021Quote: ... mEPSCs were recorded in aCSF supplemented with 10 μM N-[3-[4-(3-Aminopropylamino)butylamino]propyl]-2-naphthalen-1-ylacetamide trihydrochloride (NASPM, Tocris) to selectively block CP-AMPARs ...
-
bioRxiv - Neuroscience 2021Quote: ... aCSF was supplemented with bicuculline (20 μM, Tocris) and TTX (0.5 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and TTX (0.5 μM, Tocris). When stated ...
-
bioRxiv - Neuroscience 2021Quote: Picrotoxin (Tocris) was used at a saturating concentration of 100 µM in the ACSF solution ...